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Abstract
Background: Metatarsalgia is related to repetitive high-pressure loading under the metatarsal head (MH)
that causes pain. The high pressure under the MH can be reduced by adequately applying metatarsal pads
(MPs). Plantar pressure measurements may provide a method to objectively evaluate pressure loading
under the MH. However, it is still unclear if the decrease in plantar pressure under the MH after MP
treatment is associated with subjective improvement. This study aims to explore the correlations between
subjective pain improvement and outcome rating, and the plantar pressure parameters in metatarsalgia
patients treated using MPs.
Methods: Thirteen patients (a total of 18 feet) with secondary metatarsalgia were included in this study.
Teardrop-shaped MPs made of polyurethane foam were applied just proximal to the second MH by an
experienced physiatrist. Insole plantar pressure was measured under the second MH before and after MP
application. Visual analog scale (VAS) scores of pain were obtained from all subjects before and after 2
weeks of MP treatment. The subjects rated using four-point subjective outcome scales. The Wilcoxon
signed-rank test was used to analyze the difference between the plantar pressure parameters and VAS
scores before and after treatment. The Kruskal-Wallis test was applied to compare the plantar pressure
parameters in each outcome group. Pearson's correlation was applied to analyze the correlation between
the changes in plantar pressure parameters and VAS scores. Statistical significance was set as p < 0.05.
Results: MP application decreased the maximal peak pressure (MPP) and pressure-time integral (PTI)
under the second MH and also statistically improved subjective pain scores. However, neither the pre-
treatment values of the MPP and PTI shift in the position of the MPP after treatment, nor the age, gender
and body mass index (BMI) of the subjects were statistically correlated with subjective improvement.
Declines in the PTI and MPP values after MP application were statistically correlated with the improvement
in VAS scores (r = 0.77, R2 = 0.59, p < 0.001; r = 0.60, R2 = 0.36, p = 0.009).
Conclusion: We found that the successful decline in the PTI and MPP under the second MH after MP
application was correlated to subjective pain improvement. This study provides a strategy for the further
design and application of MPs for metatarsalgia treatment.
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Metatarsalgia is either a primary or secondary condition
that causes great discomfort in daily living [1-4]. Primary
metatarsalgia is mainly related to repetitive pressure load-
ing under the MH, which exceeds the focal tissue tolerance
and leads to inflammation and pain [1,2,5]. Many condi-
tions such as pes cavus, pes planus, hyperpronated feet,
hallux valgus and claw/hammer toe will increase pressure
loading under the MH. In another way, fat pad atrophy,
properties change (in DM or RA) or displacement (in
claw/hammer toes) will decrease the tolerance of the tis-
sue under the MH to the pressure loading. This disequilib-
rium in biomechanics is associated with metatarsalgia
[2,3]. Secondary metatarsalgia has been associated with
other conditions such as rheumatoid arthritis, ankylosing
spondylitis, gout, diabetic mellitus, nerve entrapment, etc
[1-3]. Besides pressure loading under the MH, the patho-
mechanism that includes an abnormal inflammation
process, neuropathy, fat pad atrophy, etc. is more complex
in secondary metatarsalgia.
Metatarsal pads (MPs) are placed just proximal to the MH
and can redistribute the plantar pressure and transfer pres-
sure loading under the MH to an adjacent area [6-8].
Using MPs is a useful, relatively less expensive and easily-
applied method to treat metatarsalgia [9]. However, pres-
sure under the MH may fail to reduce due to inadequate
thickness or malpositioning of the MPs. Appropriate
placement and size of the MPs are important to success-
fully relieve pressure under the MH [6-8,10]. The materi-
als of the foot insert or MPs is another important issue.
The mechanical properties of the materials including the
abilities of force-distribution, shock absorption and dura-
bility should be considered thoroughly to achieve the
maximal therapeutic effect [11,12]. In the standard labo-
ratory testing, polyurethane foams are promising materi-
als in the fabrication of foot orthotic [11]. Additional
advantages of using these materials are comfortable, inex-
pensive, and easy to modify.
Plantar pressure measurements can monitor changes in
plantar pressure before and after the MP application,
which can provide a useful guide for appropriate MP
placement [6-8,10]. Hayda et al. and Holmes et al.
showed that MP placement can effectively reduce pressure
under the MH in healthy subjects [6,7]. Our previous
study demonstrated the distribution pattern of plantar
pressure under the MH in healthy and metatarsalgia sub-
jects. MP placement was also effective in metatarsalgia
patients [8,13].
Theoretically, the symptoms of metatarsalgia should
improve after pressure under the MH is relieved by MPs.
However, subjective treatment responses of metatarsalgia
patients to MPs differed among clinical practices. The cor-
relation between the subjective treatment responses and
change in the plantar pressure parameters after MP place-
ment in metatarsalgia patients remained unclear. We
hypothesize that poor subjective improvement is related
to the failure to reduce plantar pressure under the MH
using MPs. Our study aims to obtain plantar pressure
parameters by measuring the insole plantar pressure
before and after MP placement and analysing the correla-
tion between subjective outcome ratings and pain
improvement and the plantar pressure parameters under
the MH.
Methods
Taipei Medical University Hospital Review Board
approved this study. Subjects with tenderness at the
plantar surface or weight-bearing pain under the second
MH for longer than 2 weeks that could not be relieved by
medication were recruited at the clinic of the Department
of Physical Medicine and Rehabilitation of Taipei Medical
University Hospital from July 2004 to December 2004.
After an initial examination by an experienced physiatrist,
patients with conditions such as fixed feet deformity,
severe feet malalignment (pes cavus, pes planus, hyperpr-
onated feet, hallux valgus and claw/hammer toes), previ-
ous feet surgery or major trauma, diabetic mellitus,
ankylosing spondylitis, rheumatoid arthritis and nerve
entrapments (Morton's neuroma) were excluded. Thir-
teen patients (a total of 18 feet) were included in this
study. Signed, informed consent was obtained from all
subjects.
The visual analog scale (VAS), a horizontal line 10 cm in
length, was self-scored. The word anchored at the left end
was 'no pain' and at the right end was 'almost intolerable
pain'. Patients were asked to mark the point correspond-
ing to their average pain level when walking. The VAS was
measured in centimetres using a ruler, and a score was
recorded (0.0–10.0). VAS scores for pain were recorded
for all subjects before MP placement.
The patients' shoes were checked first. Replacement with
new or other shoes was suggested if the condition of their
original shoes was not suitable for MP placement, such as
the heels being too high, toe-box too narrow, or shoes too
worn out. The only premise of the study was that the sub-
jects use suitable shoes. Insole plantar pressure was meas-
ured using Pliance 16P (Novel GmbH, Munich,
Germany), a stretchable high-resolution capacitive sensor
containing 256 sensors of 2.8 × 2.8 mm and forming a 16
× 16 matrix. The pressure sensor matrix was taped to the
plantar surface under the second MH region of a subject's
feet. Subjects performed at least three walking trials prior
to formal testing to check for any inadequacy in the sensor
positions or evident gliding between interfaces and to
determine their average most comfortable walking speed.Page 2 of 8
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at their most comfortable speed along a 10-m walkway
wearing their shoes for a total of six trials. We did not con-
trol the subjects' walking speed by any audio or visual sig-
nals; instead the subjects were requested to walk at their
most comfortable speed. If a subject's walking speed devi-
ated form his/her average most comfortable walking
speed by more than 15% in the formal test, it was aban-
doned. Pressure data were recorded at a sampling fre-
quency of 38 Hz. After the above mentioned plantar
pressure measurement was completed, a 55 × 40 × 8 mm
teardrop-shaped MP made of polyurethane foam (Schein
Orthopadia Service, Remscheid, Germany) was fixed to
the insole just proximal to the second MH by an experi-
enced physiatrist. An identical measurement protocol was
followed after MP placement.
The first and terminal steps of a row of data of each trial
were removed before data analysis to exclude the effects of
acceleration and deceleration. Peak pressure was defined
as the highest pressure in each sensor in the matrix occur-
ring in one step (from forefoot loading to push off), and
the maximal peak pressure (MPP) was identified as the
highest-pressure sensor of peak pressure under the second
MH area in the matrix. The PTI was defined as the area
under the pressure-time curve of each step at the sensor
where the MPP occurred. Two representative steps were
selected in 1 trial and a total 12 steps in a subject was
selected for further data averaging (2 steps × 6 trials). The
pre- and post-treatment positions where the MPP
occurred in the matrix were also recorded, and the dis-
tance of the shift (DS) in MPP position was calculated.
After MP placement and plantar pressure measurement,
the subjects were requested to wear their shoes with the
newly padded insole when walking. All medications for
analgesic purposes were discontinued. Patients were fol-
lowed up in the outpatient clinic after 2 weeks. The sub-
jective overall treatment response was reported as the
following 4 categories: (1) worse, (2) no change, (3) mild
improvement with a subjective improvement of <50%
and (4) major improvement with a subjective improve-
ment of >50%. VAS scores during normal walking were
recorded for all the subjects at follow-up.
The Wilcoxon signed-rank test was applied to compare
paired parameters of plantar pressure data and the VAS
score changes before and after MP application. The
Kruskal-Wallis test was applied to compare the plantar
pressure parameters and basic variables among in each
outcome group. Scheffe's test was applied for the host-hoc
test. Pearson's correlation test was applied to analyze the
correlation between the plantar pressure parameters and
change in the VAS scores after treatment. The alpha value
was set to 0.05.
Results
Basic profiles of subjects
A total of 13 subjects were included in this study. There
were 9 females and 4 males aged 50.5 ± 13.1 (range, 28 to
67) years. The symptoms involved both feet in 5 patients.
There were a total of 18 feet with symptoms of secondary
metatarsalgia – 7 on the right side and 11 on the left side.
Body weight, height, and body mass index (BMI) of the
subjects were 61.6 ± 11.6 kg, 161.7 ± 9.7 cm and 23.0 ±
3.5 kg/m2, respectively. The duration of the metatarsalgia
symptoms ranged from 2 weeks to 1 year. All the basic var-
iables of the subjects are listed in Table 1.
Plantar pressure profiles
Plantar pressure was measured in all the subjects, and the
results are listed in Table 2. The pre-treatment MPP of all
the subjects was 225.8 (95% CI, 174.5–280.0) kPa, and
the PTI was 34.8 (95% CI, 27.0–42.6) kPa·s. After MP
placement, the MPP and PTI of all the subjects decreased
significantly; their values were 199.0 (95% CI, 163.3–
234.8) kPa and 31.9 (95% CI, 24.3–39.5) kPa·s, respec-
tively.
The mean change in the MPP was -26.7 (95% CI, -52.3 to
-1.1) kPa, and the PTI was -2.9 (95% CI, -5.0 to -0.9)
kPa·s (Table 2). However, we still found 4 feet in which
the MPP was elevated after MP placement (Figure 1). The
position of MPP occurrence in the matrix shifted signifi-
cantly after treatment, and the mean distance of shifting
was 3.6 (95% CI, 2.5 to 4.5) mm.
Table 1: Basic variables of subjects
Total (mean ± SD) Range
Age (years) 50.5 ± 13.1 28 ~ 67
BMI (kg/m2) 23.0 ± 3.5 18.3 ~ 28.9
Symptom duration (weeks) 18.9 ± 17.0 2 ~ 52
Gender (F:M) 9:4
Involved side (right: left) 7:11
BMI, body mass index.Page 3 of 8
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None of the subjects dropped out or discarded their newly
padded insole shoes in the follow-up. The VAS scores dur-
ing normal walking decreased significantly after MP place-
ment. The mean change in the VAS scores was -1.0 (95%
CI, -1.5 to -0.5). The patient's subjective outcome rating at
follow-up rated 3 feet as 'worse', 3 as 'no change', 6 as
'mild improvement' and 6 as 'major improvement'. The
plantar pressure parameters for each outcome group are
listed in Table 3. We found that the decline in the MPP
and PTI after MP placement differed significantly in each
outcome group (p = 0.033 and p = 0.034, respectively).
The patient's age, gender or symptom duration did not
differ significantly within an outcome group. Declines in
the PTI and MPP values after MP placement significantly
correlated to the decrease in the VAS scores (r = 0.77, R2 =
0.59, p < 0.001; r = 0.60, R2 = 0.36, p < 0.009) (Figure 2).
The pre- and post-treatment MPP and PTI values or the DS
in the MPP position in the matrix were not statistically
correlated to changes in the VAS (Table 4).
Discussion
In previous studies, both barefoot and insole plantar pres-
sure measurements were conducted to monitor plantar
pressure [5,14-16]. However, the barefoot measurement
may not reflect the actual biomechanical effect after MP
placement in the daily life, since the interaction among
MPs, feet and shoes cannot be studied. To study the effects
of MPs within the shoe environment, Chang et al. con-
ducted a multi-step insole protocol to demonstrate the
pressure redistribution effects of MPs in healthy subjects
[15]. We also used a multi-step protocol with insole
plantar pressure measurement to simulate the daily walk-
ing activity of the subjects with original and newly padded
shoes as closely as possible. We believe this protocol can
provide more accurate estimates of the plantar pressure
parameters than barefoot or single-step protocols.
Previously, we demonstrated that optimal positioning of
the MPs reduces 28% of peak pressure under the MH, and
this position was at just proximal to the second MH using
barefoot measurement [8]. We applied this finding to our
current research but found an average decline of only
11.8% in the MPP value by insole measurement; this was
much less than the decline in the MPP value observed in
our previous data. We believe that this discrepancy is
because of the biomechanical interaction among the
shoes, MPs and feet when using insole measurement.
Hayda et al. suggested that positioning the MP at 5 mm
distal to the MH causes the greatest reduction in plantar
pressure; in addition, they found that plantar pressure
failed to decline in 40% of the male feet in his study; this
was 22% in our study [7]. These conflicting findings may
also be a reflection of the considerable individual ana-
tomical and biomechanical variations that influence the
optimal positioning of MPs. Moreover, using an external
body marker to place the MPs is not a reliable method to
reduce pressure under the MH. In conclusion, we suggest
that plantar pressure measurement can be used as an
objective tool to guide MP placement. Further, we suggest
that the optimal position of the MPs should be individu-
alized by using the patients' own shoe. Replacement or
changing to different-sized MPs should be considered
when MP placement fails to achieve PTI and MPP reduc-
tion by insole plantar pressure measurement.
We found that the declines in the PTI and MPP under the
MH after MP application correlated with significant pain
improvement. The increase in the MPP of 4 feet after MP
placement is also noteworthy; of these, 3 rated the symp-
toms as worse, while one rated as no improvement during
the follow-up. This finding demonstrates that subjects in
whom MP placement failed to reduce pressure under the
MH may experience no subjective improvement. How-
ever, Postema et al. showed that the reduction in peak
plantar pressure was not correlated to pain score improve-
ment in metatarsalgia patients treated by a rocker bar [5].
Even the biomechanical effects of the rocker bar and MPs
differed; the former decreased the inclination of the met-
atarsus, while the latter redistributed the pressure to an
adjacent tissue. However, both foot orthotic were benefi-
cial in reducing pressure under the MH. We believe that
these inconsistent results may be related to the pain mod-
ulation effect of the MPs. Since the MPs reduced pressure
under the MH by transferring pressure loading to the adja-
cent tissues, this phenomenon may increase the sensory
input of the deep pressure (large-fibre afferents) of the
adjacent tissue; metatarsalgia could be modulated accord-
ing to the 'gate-control theory' [17,18]. Hodge et al. found
only 32% variance in pain was determined by measuring
the average pressure under the MH in metatarsalgia due to
rheumatoid arthritis, and he concluded that the pain sen-
Table 2: Plantar pressure parameters and VAS (mean and 95% CI) before and after MP placement
Pre-treatment Post-treatment Change after treatment p value
MPP (kPa) 225.8 (174.5 ~ 280.0) 199.0 (163.3 ~ 234.8) -26.7 (-52.3 ~ -1.1) 0.028
PTI (kPa·s) 34.8 (27.0 ~ 42.6) 31.9 (24.3 ~ 39.5) -2.9 (-5.0 ~ -0.9) 0.005
VAS 4.9 (4.4 ~ 5.5) 3.9 (3.1 ~ 4.7) -1.0 (-1.5 ~ -0.5) 0.001
MPP, maximal peak pressure; PTI, pressure time integral; VAS, visual analog scale; CI, confidence interval.Page 4 of 8
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Changes in the PTI and MPP values after MP placement in each outcome groupFigur  1
Changes in the PTI and MPP values after MP placement in each outcome group. The difference between two 
parameters differed significantly in each outcome group (p < 0.05). Note that the MPP of 4 feet increased after MP placement–
3 rated the outcome as 1, while one rated it as no change, i.e. Subjective outcome rating: 1, worse; 2, no change; 3, improve-
ment <50%; 4, improvement >50%. MPP, maximal peak pressure; PTI, pressure time integral.
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Postema et al. noted that a subject with pain preferred to
use a custom moulded insole over a rocker bar, although
both orthrosis reduce plantar pressure [5]. We believe that
the pain modulation effect of MPs may be one of mecha-
nisms of pain relief in metatarsalgia. Further study is
needed to examine this hypothesis.
We found that the decline in the PTI value after MP place-
ment correlated well with that in the VAS scores, while the
decline in the MPP value correlated moderately (r = 0.77,
R2 = 0.59 versus r = 0.60, R2 = 0.36). There are several pos-
sible explanations for this finding. First, considering a
temporal effect, the PTI provides a better estimation of
overall pressure loading under the MH than the MPP,
which is a point estimation. Second, nociceptors have
slower responses to increasing pressure than mechanore-
ceptors [19]. The brief duration of the peak pressure under
the MH may be insufficient to cause high frequency firing
of the nociceptors [14,19]. Based on our findings, we sug-
gest that the optimal treatment should be lowering the PTI
under the MH as much as possible.
We found that the MPP and PTI values before and after
treatment did not correlate to the subjective outcome rat-
ing or pain improvement. Previous studies showed that
plantar pressure of asymptomatic subjects exhibit large
variation [6,13,14]. The normal thresholds of plantar
pressure under a human MH that induce tissue damage
are difficult to determine. Hence, it is difficult to set treat-
ment goals for lowering the PTI or MPP to a constant
threshold. Although a shift in the position of the peak
pressure may be observed after MP application, we found
that the distance by which the peak pressure shifted after
treatment was not correlated to the subjective outcomes
or declines in the VAS scores. We concluded that it is nei-
ther to shift the 'peak pressure site' from the painful met-
atarsal area as far as possible nor lower the PTI and MPP
to a 'normal threshold' to achieve a good treatment result.
There were some insufficiencies in our study. First, we
studied a small number of cases. The statistical power of
our study was 0.25–0.33 at a sample size of 18, and the
alpha level set as 0.05. The type II error should be consid-
ered when the statements of the differences between vari-
ables were insignificant. Second, to ensure homogeneity
of the subjects, we excluded conditions such as severe
hyperpronated feet, pes cavus, claw/hammer toes, and
hallux valgus, which are not uncommon in clinical prac-
tice. The biomechanics of these conditions are various and
may require different orthrosis considerations [3,9].
Third, analysis of the data obtained by combining that
Table 3: Plantar pressure parameters (mean and 95% CI) in each subjective outcome group
Subjective outcome 1 (n = 3) 2 (n = 3) 3 (n = 6) 4 (n = 6) p
pre-MPP (kPa) 175.7 (132.0 ~ 219.4) 190.9 (-30.4 ~ 412.2) 215.5 (167.8 ~ 263.2) 278.5 (278.4 ~ 444.5) 0.621
post-MPP 208.2 (120.8 ~ 295.6) 176.0 (-5.9 ~ 357.8) 181.4 (144.2 ~ 218.6) 223.7 (107.7 ~ 339.7) 0.683
MPP-change 32.5 (-11.9 ~ 96.9) -14.9 (-60.0 ~ 30.2) -34.1 (-46.2 ~ -22.0) -54.8 (-132.1 ~ 22.6) 0.033
pre-PTI (kPa·s) 26.0 (17.4 ~ 34.6) 37.7 (-5.6 ~ 81.0) 30.7 (24.1 ~ 37.4) 41.9 (17.5 ~ 66.3) 0.730
post-PTI 2.80 (18.4 ~ 37.6) 35.9 (-7.8 ~ 79.7) 27.4 (21.3 ~ 33.6) 36.3 (11.4 ~ 61.1) 0.981
PTI-change 2.1 (-0.9 ~ 5.0) -1.8 (-3.1 ~ -0.4) -3.3 (-6.0 ~ -0.6) -5.7 (-10.9 ~ -4.4) 0.034
DS of MPP (mm) 5.8 (4.0 ~ 6.0) 2.9 (0 ~ 8.8) 2.7 (1.5 ~ 4.0) 3.0 (1.2 ~ 5.0) 0.086
pre, pre-treatment; post, post-treatment; change, post-treatment value – pre-treatment value; DS, distance of shifting; CI, confidence interval. 
Subjective outcome rating: 1, worse; 2, no change; 3, improvement <50%; 4, improvement >50%.
Table 4: Pearson's correlation test between the change of VAS and the plantar pressure parameters
Correlation with VAS-change r(R2) p-value
pre-MPP -0.447 (0.20) 0.063
post-MPP -0.21 (0.04) 0.402
MPP-change 0.60 (0.36) 0.009
pre-PTI -0.292 (0.09) 0.240
post-PTI -0.093 (0.008) 0.714
PTI-change 0.77 (0.59) <0.001
DS of MPP 0.01 (<0.001) 0.969
pre, pre-treatment; post, post-treatment; change, post-treatment value – pre-treatment value; DS, distance of shifting.Page 6 of 8
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The scatter graph with regression line (95% CI) of the changes in the PTI and MPP versus changes in the VAS score after MP placementFigure 2
The scatter graph with regression line (95% CI) of the changes in the PTI and MPP versus changes in the VAS 
score after MP placement. The correlations of the changes in VAS scores with changes in the MPP and PTI values were sta-
tistically significant (r = 0.77, R2 = 0.59, p < 0.001; r = 0.60, R2 = 0.36, p < 0.009). MPP, maximal peak pressure; PTI, pressure 
time integral; VAS, visual analog scale. CI, confidence interval.
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from both feet of the same person as in the case of some
subjects may violate the assumption of independence of
the data set. There is still no data available to analyze the
difference between the characteristics of unilateral and
bilateral metatarsalgia patients. The statistical methods
used to analyze the correlated dataset in the treatment
response of patients who had bilateral metatarsalgia
should be more adequate. Finally, our subjects were fol-
lowed up after 2 weeks. Follow-up for a longer period may
be needed to observe long-term outcomes.
Our findings have several implications. First, using real-
time plantar pressure measurements before and after MP
placement can provide a tool to monitor treatment in
clinical practice. Readjustment of MP placements for
those who failed to demonstrate a decline in the PTI and
MPP values after treatment should be considered to
improve treatment results. Second, the PTI can estimate
overall pressure-loading of the tissue under the MH and
may be a more important marker than the MPP. This find-
ing can be applied to a new insert or insole design. Finally,
the absolute values of the MPP and PTI are not correlated
to the treatment results. Successful lowering of the MPP
and PTI is key for symptom relief.
Conclusion
Applying MPs is an effective method to reduce pressure
loading under the MH and relieve the symptoms of meta-
tarsalgia. We found that the decline in the PTI and MPP
values after MP application was correlated to subjective
pain improvement. We suggest that MP placement for
patients with metatarsalgia should be individualized and
adjusted by the monitoring of the plantar pressure meas-
urements. This study can also provide a strategy for further
orthrosis design and may be used for metatarsalgia treat-
ment.
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